Mark R. Dowling, Edward R. Scheffer Cliff, Anthony Jeffrey, Catelyn Cashion, Stephen Boyle, Jian Li, Thomas Buss, R. MacDonald, Anastasia Edelkina, Hamish W Scott, Nicole O'Leary, Michelle Wendy Keir, Safia Belbachir, D. Westerman, Constantine S. Tam, P. Joy Ho, Simon J Harrison, Allison Barraclough, Shafqat Inam, Emily Blyth, Andrea Henden, Vinay Vanguru, Michael Dickinson
ABSTRACT: In this retrospective analysis of 584 patients who received chimeric antigen receptor T-cell therapy for large B-cell lymphoma at 6 Australian centers, no association was found between time of infusion and outcome, accounting for confounders, suggesting minimal clinical impact of chronobiology in this setting.